A Study of Combined Deferasirox, Vitamin D and Azacytidine in High Risk MDS

NCT01718366 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

MDS

Interventions

DRUG: Deferasirox, Vitamin D and Azacitidine

Sponsor

Groupe Francophone des Myelodysplasies

Collaborators

[object Object]